Evidence map›Paper›PMID 33281182›Full record

ArticleThe American journal of case reports2020

Sustained Ventricular Tachycardia as a Harbinger of Cardiac Amyloidosis.

Oreoluwa Oladiran, Adeolu Oladunjoye, Olubunmi O Oladunjoye, Anish Paudel, Ibiyemi Oke, Lisa Motz, Sarah Luber, Anthony Licata

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Sustained Ventricular Tachycardia as the first presentation of transthyretin amyloid cardiomyopathy.Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Oreoluwa OladiranCardiovascular Division, Department of Medicine, Tower Health Medical Group, Reading Hospital, West Reading, PA, USA.
Adeolu OladunjoyeDivision of Medical Critical Care, Boston Children's Hospital, Boston, MA, USA.
Olubunmi O OladunjoyeDepartment of Medicine, Reading Hospital, Tower Health System, West Reading, PA, USA.
Anish PaudelDepartment of Medicine, Reading Hospital, Tower Health System, West Reading, PA, USA.
Ibiyemi OkeDepartment of Medicine, Reading Hospital, Tower Health System, West Reading, PA, USA.
Lisa MotzDepartment of Medicine, Reading Hospital, Tower Health System, West Reading, PA, USA.
Sarah LuberDepartment of Medicine, Reading Hospital, Tower Health System, West Reading, PA, USA.
Anthony LicataCardiovascular Division, Department of Medicine, Tower Health Medical Group, Reading Hospital, West Reading, PA, USA.
Reading Hospital · USBoston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Cardiac amyloidosis is an infiltrative cardiomyopathy caused by the extracellular deposition of insoluble precursor protein amyloid fibrils. These depositions of protein amyloid fibrils are found on the atria and ventricles and can cause a wide array of arrhythmias; however, sustained ventricular arrhythmias are quite uncommon. CASE REPORT A 71-year-old man with a history of hypertension developed a sudden onset of shortness of breath, profuse diaphoresis, lightheadedness, and presyncope. Upon emergency medical services' arrival, an initial electrocardiogram revealed wide complex tachycardia with a heart rate of 220 to 230 beats per min. He was subsequently given, in succession, magnesium, adenosine, and amiodarone with no change in heart rate or rhythm. Due to ongoing symptoms of diaphoresis and the development of dyspnea, he underwent direct current cardioversion and was converted from ventricular tachycardia to atrial fibrillation at controlled rates. A transthoracic echocardiogram and cardiac magnetic resonance imaging showed features suspicious for cardiac amyloidosis. A subsequent 99m technetium pyrophosphate single-photon emission computerized tomography scan revealed a grade 3 visual uptake and a heart-to-contralateral lung ratio of 1.92, consistent with transthyretin amyloidosis. The patient was treated with tafamidis and an implantable cardioverter-defibrillator for secondary prevention of ventricular arrhythmia. CONCLUSIONS This case highlights the need to consider cardiac amyloidosis in the differential diagnoses of patients with persistent ventricular arrhythmia and no prior history of heart disease.

Indexed as

AmiodaroneAmyloid Neuropathies, FamilialDefibrillators, ImplantableTachycardia, VentricularAgedElectric CountershockHumansMaleAmiodarone

Identifiers

PMID33281182
PMCPMC7733151
OpenAlexW3096075751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.